Original news and analysis on international IP policy
2014 brought major changes to the United States intellectual property system, particularly in the area of patent law. 2015 promises more of the same, as the new Supreme Court ruling in Teva Pharmaceuticals USA v. Sandoz attests. Here’s a discussion of Teva and other key cases and developments to watch this year.
Several years ago, the World Intellectual Property Organization set up a project aimed at helping bring together those with intellectual property rights and those with ideas for research to develop medical products for people in need. The project, WIPO Re:Search, has gathered numerous partners and is beginning to look ahead to its next phases, including the possible eventuality of drug development, according to the WIPO secretariat.
A new report from the World Health Organization examines the Global action plan for the prevention and control of noncommunicable diseases 2013-2020 (known as the Global NCD Action Plan) and provides some “lessons learnt from implementation.” The report calls for urgent action by governments to stop the “epidemic” of cancer and mostly preventable diseases from sources like tobacco use, salt intake, physical inactivity, and high blood pressure. This includes ensuring treatment is available and affordable, it says.
Today's rejection by the Patent Office Controller of India of a patent application by Gilead company for a key drug against hepatitis C is being hailed by advocates as a path to dramatically lower costs of treatment for the disease. Hepatitis C has been noteworthy for exorbitantly priced medicines over the past year. A look at the decision shows that a provision in India's law continues to stop patent applications if they fail to show sufficient novelty and inventive step - and are subject to opposition.
The upcoming World Health Organization Executive Board annual January meeting will be 10 days. Included in the list of issues to be addressed are the engagement of the organisation with lobbyists and donors, antimicrobial resistance, and the potential establishment of a pooled fund of voluntary contributions for research and development for diseases primarily affecting developing countries.
The year 2015 has dawned as usual with the fanfare of greater things to come. Caribbean projects are in the pipeline, along with activities to enhance competitiveness and many gallant efforts by well- meaning non-governmental and International organizations. The research has shown, however, that without the impetus of effort that originates from amongst the local innovators, there is no real change and no great advancement.
The population in Uganda has been growing rapidly. The country now has 35 million people. In order to provide quality services to its citizens and to improve the national competitiveness through administration innovation, the government has adopted free and open source software as the preferred mode of operation for electronic government (e-government) services and platforms.
The World Intellectual Property Organization this week issued its 2014 edition of the World Intellectual Property Indicators report, finding growth in intellectual property filings in China and the United States, and decline in Europe and Japan.
BRUSSELS – In an age where technology and globalisation play an ever-increasing role, it must be asked whether the policy goals and structures of the intellectual property system remain relevant in Europe and beyond. In this regard, the newly elected “Junker Commission,” in office from 1 November, offers a chance to issue new IP strategies and strengthen the pre-existent IP infrastructures.
In light of such changes, the Pan-European Intellectual Property Summit (IP Summit) with its unique blend of keynote speakers and 25 workshops, running from reforms at the European and national levels to sectorial business practices across the spectrum of IP fields, provided once again a platform for fresh and critical ideas.
China has been filing patents at far greater rates than any other nation on earth in recent years. This week, a Thomson Reuters report broke down that growth and compared it with other leading nations on the basis of innovation.
As staff strikes continue and the European Patent Office's Administrative Council prepares for what could be a contentious 11 December meeting, opinions are split over the effect of the turmoil on the office's role in Europe's unitary patent.
A seminar on innovation and access to medicine last week examined the issue of access to hepatitis C treatment, looking at the HIV/AIDS path. Voluntary licences, such as the one entered by Gilead for its hepatitis drugs, have been applauded but such licences often do not cover middle-income countries, which are home to the bulk of hepatitis C patients, and whose poor populations remain unable to access treatment.